Literature DB >> 23486534

Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection.

Jeong-Hwan Hwang1, Pyoeng Gyun Choe, Nak Hyun Kim, Ji Hwan Bang, Kyoung-Ho Song, Wan Beom Park, Eu Suk Kim, Sang Won Park, Hong-Bin Kim, Nam Joong Kim, Myoung-Don Oh, Kang Won Choe.   

Abstract

Korea is a low prevalence country for human immunodeficiency virus (HIV) infection and has an intermediate tuberculosis (TB) burden. We previously reported that the incidence of TB in HIV-infected patients was 9.6 cases per 100 person-years (P-Y) between 1988 and 1997. The aims of the present study were to measure any change in incidence from the previous study, and to identify risk factors for TB in HIV-infected patients. We reviewed all medical records of HIV-infected patients who were followed-up in one tertiary hospital between 1998 and 2010. Over the total observation period of 5858.33 P-Y, TB developed in 70 patients (1.19 cases per 100 P-Y; 95% confidence interval [CI], 0.91-1.47 cases per 100 P-Y). Based on Poisson regression, one risk factor associated with TB was an initial CD4+ cell count below 200 cells/µL (relative risk, 2.34; 95% CI, 1.47-3.73). Mean CD4+ cell counts of pulmonary, extrapulmonary, and both pulmonary and extrapulmonary TB were 179.8 cells/µL, 138.3 cells/µL, and 114.2 cells/µL, respectively (P = 0.55). In conclusion, the incidence of TB in HIV-infected patients has decreased since the previous study. An initial CD4+ cell count below 200 cells/µL is an independent risk factor for development of TB in HIV-infected patients.

Entities:  

Keywords:  HIV; Incidence; Risk Factors; Tuberculosis

Mesh:

Year:  2013        PMID: 23486534      PMCID: PMC3594599          DOI: 10.3346/jkms.2013.28.3.374

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  19 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  D V Havlir; P F Barnes
Journal:  N Engl J Med       Date:  1999-02-04       Impact factor: 91.245

2.  Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.

Authors:  Alexey Kruk; Wendy Bannister; Daria N Podlekareva; Nelly P Chentsova; Aza G Rakhmanova; Andrzej Horban; Perre Domingo; Amanda Mocroft; Jens D Lundgren; Ole Kirk
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

3.  Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea.

Authors:  M D Oh; S W Park; H B Kim; U S Kim; N J Kim; H J Choi; D H Shin; J S Lee; K Choe
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

4.  Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.

Authors:  H C Bucher; L E Griffith; G H Guyatt; P Sudre; M Naef; P Sendi; M Battegay
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

5.  Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.

Authors:  Young Ae Kang; Hye Won Lee; Ho Il Yoon; BeLong Cho; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

6.  Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.

Authors:  Alison D Grant; Salome Charalambous; Katherine L Fielding; John H Day; Elizabeth L Corbett; Richard E Chaisson; Kevin M De Cock; Richard J Hayes; Gavin J Churchyard
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

7.  Epidemiology and clinical features of HIV infection/AIDS in Korea.

Authors:  June Myung Kim; Goon Jae Cho; Sung Kwan Hong; Kyung Hee Chang; Joo Sup Chung; Young Hwa Choi; Young Goo Song; Aejung Huh; Joon Sup Yeom; Kkot Sil Lee; Jun Yong Choi
Journal:  Yonsei Med J       Date:  2003-06-30       Impact factor: 2.759

8.  Accelerated course of human immunodeficiency virus infection after tuberculosis.

Authors:  C Whalen; C R Horsburgh; D Hom; C Lahart; M Simberkoff; J Ellner
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

9.  Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

Authors:  Brian G Williams; Christopher Dye
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

10.  Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.

Authors:  B E Jones; S M Young; D Antoniskis; P T Davidson; F Kramer; P F Barnes
Journal:  Am Rev Respir Dis       Date:  1993-11
View more
  9 in total

1.  Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study.

Authors:  Leila Molaeipoor; Jalal Poorolajal; Minoo Mohraz; Nader Esmailnasab
Journal:  Epidemiol Health       Date:  2014-10-30

Review 2.  The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections.

Authors: 
Journal:  Infect Chemother       Date:  2016-03-31

3.  Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study.

Authors:  Ausman Ahmed; Desalew Mekonnen; Atsede M Shiferaw; Fanuel Belayneh; Melaku K Yenit
Journal:  BMJ Open       Date:  2018-02-06       Impact factor: 2.692

4.  Multistate recursively imputed survival trees for time-to-event data analysis: an application to AIDS and mortality post-HIV infection data.

Authors:  Leili Tapak; Michael R Kosorok; Majid Sadeghifar; Omid Hamidi
Journal:  BMC Med Res Methodol       Date:  2018-11-13       Impact factor: 4.615

Review 5.  History of Acquired Immune Deficiency Syndrome in Korea.

Authors:  June Myung Kim; Nam Joong Kim; Jun Yong Choi; Bum Sik Chin
Journal:  Infect Chemother       Date:  2020-06

6.  Indian tubercular belly: A prospective study of 140 patients of abdominal tuberculosis and their outcomes.

Authors:  Monika Keena; Gopal Chawla; Ujjwal Sonika; Nupur Abrol; Shrikant Hiremath; Virender Kumar Meena
Journal:  J Family Med Prim Care       Date:  2022-06-30

7.  Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study.

Authors:  Yong-Soo Kwon; Yee Hyung Kim; Jae-Uk Song; Kyeongman Jeon; Junwhi Song; Yon Ju Ryu; Jae Chol Choi; Ho Cheol Kim; Won-Jung Koh
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

8.  End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study.

Authors:  Jinsoo Min; Soon Kil Kwon; Hye Won Jeong; Joung-Ho Han; Yeonkook Joseph Kim; Minseok Kang; Gilwon Kang
Journal:  J Korean Med Sci       Date:  2018-12-13       Impact factor: 2.153

9.  Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients.

Authors:  Chan Mi Lee; Eunyoung Lee; Ji Hwan Bang; Sang-Won Park; Wan Beom Park; Myoung-Don Oh; Nam Joong Kim
Journal:  Infect Chemother       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.